7.00
price up icon0.57%   0.04
after-market Dopo l'orario di chiusura: 6.97 -0.03 -0.43%
loading
Precedente Chiudi:
$6.96
Aprire:
$7
Volume 24 ore:
969.88K
Relative Volume:
0.99
Capitalizzazione di mercato:
$350.72M
Reddito:
$124.00K
Utile/perdita netta:
$-49.99M
Rapporto P/E:
-4.142
EPS:
-1.69
Flusso di cassa netto:
$-31.03M
1 W Prestazione:
+1.16%
1M Prestazione:
+44.33%
6M Prestazione:
+1.60%
1 anno Prestazione:
+10.06%
Intervallo 1D:
Value
$6.9051
$7.21
Intervallo di 1 settimana:
Value
$6.28
$7.21
Portata 52W:
Value
$3.785
$14.60

Candel Therapeutics Inc Stock (CADL) Company Profile

Name
Nome
Candel Therapeutics Inc
Name
Telefono
617-916-5445
Name
Indirizzo
117 KENDRICK STREET, NEEDHAM
Name
Dipendente
38
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
CADL's Discussions on Twitter

Confronta CADL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CADL
Candel Therapeutics Inc
7.00 348.71M 124.00K -49.99M -31.03M -1.69
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-30 Ripresa H.C. Wainwright Buy
2025-02-20 Iniziato Citigroup Buy
2025-02-19 Iniziato Canaccord Genuity Buy
2025-02-07 Iniziato BofA Securities Buy
2022-12-02 Iniziato H.C. Wainwright Buy
2021-11-19 Iniziato BMO Capital Markets Outperform
2021-08-23 Iniziato Credit Suisse Outperform
2021-08-23 Iniziato Jefferies Buy
2021-08-23 Iniziato UBS Buy
Mostra tutto

Candel Therapeutics Inc Borsa (CADL) Ultime notizie

pulisher
Jul 24, 2025

Candel Therapeutics' CAN-2409 Receives European Orphan Designation for Pancreatic Cancer Treatment - citybuzz -

Jul 24, 2025
pulisher
Jul 24, 2025

Can Candel Therapeutics Inc. stock recover from recent declineExceptional return forecasts - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Small cap wrap: Blockmate Ventures, Candel Therapeutics, HIVE Digital, American Resources... - Proactive financial news

Jul 24, 2025
pulisher
Jul 24, 2025

Candel Therapeutics receives EMA Orphan Designation for immunotherapy candidate CAN-2409 - Proactive financial news

Jul 24, 2025
pulisher
Jul 24, 2025

Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of Pancreatic Cancer - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

Revolutionary Pancreatic Cancer Treatment Shows 31.4-Month Survival, Secures Critical EU Designation - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

Is Candel Therapeutics Inc. a good long term investmentSuperior profit margins - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Candel Therapeutics Inc. Stock Analysis and ForecastSkyrocketing returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Candel Therapeutics Inc. stock priceTremendous portfolio expansion - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Candel Therapeutics Inc. stockFree Stock Market Knowledge Sharing - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

(CADL) Trading Report - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 17, 2025

What makes Candel Therapeutics Inc. stock price move sharplyShort Squeeze Radar - beatles.ru

Jul 17, 2025
pulisher
Jul 16, 2025

Candel Therapeutics (CADL) Shares Soar 9.60% - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

Candel Therapeutics (CADL) Has a New Rating from Freedom Capital Markets - The Globe and Mail

Jul 15, 2025
pulisher
Jul 14, 2025

Freedom Broker initiates coverage on Candel Therapeutics stock with Buy rating - Investing.com Nigeria

Jul 14, 2025
pulisher
Jul 14, 2025

Freedom Broker initiates coverage on Candel Therapeutics stock with Buy rating By Investing.com - Investing.com South Africa

Jul 14, 2025
pulisher
Jul 11, 2025

(CADL) Investment Report - news.stocktradersdaily.com

Jul 11, 2025
pulisher
Jul 10, 2025

Brookline Capital Initiates Candel Therapeutics(CADL.US) With Buy Rating, Announces Target Price $25 - 富途牛牛

Jul 10, 2025
pulisher
Jul 10, 2025

Candel Therapeutics Added to Russell Indexes, Analysts Forecast Upside of 319.85% - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

Candel Therapeutics added to multiple Russell value indexes By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

Brookline Capital initiates Candel Therapeutics stock with Buy rating, $25 target - Investing.com Nigeria

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics Added To Multiple Russell Value Indexes In 2025 Reconstitution - 富途牛牛

Jul 09, 2025
pulisher
Jul 09, 2025

Market movers: Meta, Nvidia, Candel Therapeutics, Ocean Power Technologies... - Proactive financial news

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics: Russell Inclusion and Clinical Catalysts Drive Biotech Upside - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution - The Manila Times

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics added to multiple Russell value indexes - Investing.com

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics, Inc. Gains Inclusion in Multiple Russell Value Indexes During 2025 Annual Reconstitution - Quiver Quantitative

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics Expands Russell Index Presence with - GlobeNewswire

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics expands Russell Index presence following 2025 reconstitution - Proactive financial news

Jul 09, 2025
pulisher
Jun 30, 2025

Candel Therapeutics stock initiated with Buy rating at H.C. Wainwright - Investing.com India

Jun 30, 2025
pulisher
Jun 27, 2025

One Candel Therapeutics Insider Raised Stake By 22% In Previous Year - Yahoo Finance

Jun 27, 2025
pulisher
Jun 25, 2025

Candel Therapeutics (CADL) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance

Jun 25, 2025
pulisher
Jun 24, 2025

Market movers: Carnival, Uber, Ideal Power, Candel Therapeutics... - Proactive Investors

Jun 24, 2025
pulisher
Jun 24, 2025

Candel Therapeutics announces $15M direct offering to support CAN-2409 launch preparations - Proactive Investors

Jun 24, 2025
pulisher
Jun 23, 2025

Candel Therapeutics names Charles Schoch as CFO after interim tenure - Proactive financial news

Jun 23, 2025
pulisher
Jun 23, 2025

Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer - The Globe and Mail

Jun 23, 2025
pulisher
Jun 21, 2025

Trend Tracker for (CADL) - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 18, 2025

Candel Therapeutics Elects New Directors at Annual Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 15, 2025

Candel Therapeutics, Inc.'s (NASDAQ:CADL) latest 15% decline adds to one-year losses, institutional investors may consider drastic measures - simplywall.st

Jun 15, 2025
pulisher
Jun 13, 2025

Neoantigen Cancer Vaccines Industry Analysis Report 2025 with Tariff-Adjusted Forecasts and Analytics to 2030 - GlobeNewswire

Jun 13, 2025

Candel Therapeutics Inc Azioni (CADL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):